Relation of serum lipids and lipoproteins with progression of CKD: The CRIC study (Q33835707)

29 July 2017

Relation of serum lipids and lipoproteins with progression of CKD: The CRIC study (English)

1 reference

29 July 2017

0 references

CRIC Study Investigators

13

object named as

CRIC Study Investigators

1 reference

29 July 2017

6

Lawrence J Appel

1 reference

29 July 2017

1

Mahboob Rahman

1 reference

29 July 2017

Wei Yang

2

1 reference

29 July 2017

Sanjeev Akkina

3

1 reference

29 July 2017

Arnold Alper

4

1 reference

29 July 2017

Amanda Hyre Anderson

5

1 reference

29 July 2017

Jiang He

7

1 reference

29 July 2017

Dominic S Raj

8

1 reference

29 July 2017

Jeffrey Schelling

9

1 reference

29 July 2017

Louise Strauss

10

1 reference

29 July 2017

Valerie Teal

11

1 reference

29 July 2017

Daniel J Rader

12

1 reference

29 July 2017

15 May 2014

1 reference

Clinical Journal of the American Society of Nephrology

29 July 2017

1 reference

29 July 2017

9

1 reference

29 July 2017

1190-1198

1 reference

29 July 2017

7

1 reference

Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

Longitudinal progression trajectory of GFR among patients with CKD.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

Lipid disorders and their relevance to outcomes in chronic kidney disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

New insights into lipid metabolism in chronic kidney disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

Lipotoxicity and impaired high density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

Variability of creatinine measurements in clinical laboratories: results from the CRIC study

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

The effect of lipoproteins on the development and progression of renal disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

Disorders in high-density metabolism with insulin resistance and chronic kidney disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

Epidemiology, pathophysiology and therapeutic implications of lipoprotein(a) in kidney disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

Cholesterol and the risk of renal dysfunction in apparently healthy men.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

Random-effects models for longitudinal data

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

NMR identifies atherogenic lipoprotein abnormalities in early diabetic nephropathy that are unrecognized by conventional analysis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

Hypertriglyceridemia: an independent risk factor of chronic kidney disease in Taiwanese adults

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

Lipid and lipoprotein metabolism in chronic kidney disease.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

Prospective study of lipoprotein(a) as a risk factor for deteriorating renal function in type 2 diabetic patients with overt proteinuria

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

Factors associated with lipoprotein(a) in chronic kidney disease

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

Serum triglycerides are a predictive factor for the development and the progression of renal and retinal complications in patients with type 1 diabetes

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

Predictors of new-onset kidney disease in a community-based population

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4078958

Effects of reduced renal mass on tissue lipids and renal injury in hyperlipidemic rats

29 October 2018

1 reference

12 December 2020

Renal injury of diet-induced hypercholesterolemia in rats

1 reference

12 December 2020

Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency

1 reference

12 December 2020

Increased serum lipoprotein(a) levels in patients with early renal failure

1 reference

12 December 2020

Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy

1 reference

12 December 2020

Identifiers

DOI

10.2215/CJN.09320913

1 reference

29 July 2017

1 reference

29 July 2017

1 reference